Regulatory T lymphocytes (Tregs) have been implicated in preserving immunologic homeostasis and their absence may lead to autoimmunity. During the previous funding period of this competitive renewal application, we have uncovered and characterized a novel population of CD8 Tregs in humans. These CD8 Tregs are inducible through IL-15 combined with low-affinity T cell receptor stimulation;they express a unique phenotype;CD8+CD45RA+CCR7+ and function by disrupting membrane-proximal signaling events in CD4 T cells. Specifically, CD8+CCR7+ Tregs prevent phosphorylation of the adaptor molecule Zap70 in adjacent CD4 T cells undergoing activation. In patients with rheumatoid arthritis (RA) and in elderly individuals induction of these CD8 Tregs is markedly impaired. Generation of CD8+CCR7+ Tregs is enhanced in the presence of the mTOR inhibitor Rapamycin. The current application is designed to understand, on a molecular level, how CD8+CCR7+ are induced;why induction is hampered in patients with rheumatoid arthritis and through which pathways adoptively transferred CD8+CCR7+ Tregs suppress the inflammatory activity of rheumatoid synovitis. Finally, we will explore how CD8+CCR7+ Tregs communicate with adjacent CD4 T cells and seek to identify receptor-ligand pairs mediating the negative signal.
Specific Aim 1 is designed to examine the transcriptional regulation of FOXP3 in successful and failed induction of CD8+CCR7+ Tregs and to investigate how Rapamycin-modulated signaling pathways can be exploited to optimize generation.
Specific Aim 2 is devoted to define the precursor cells giving rise to CD8+CCR7+ Tregs and to mechanistically link the defective DNA repair machinery in RA with the failure to produce functional CD8 Tregs.
Specific Aim 3 is focused on confirming and extending studies of the in vivo function of CD8+CCR7+ Tregs in suppressing rheumatoid synovitis;relying on a human synovium-SCID chimera model.
Specific Aim 4 is dedicated to unravel the molecular mechanism through which CD8 Tregs prohibit CD4 T cells from proceeding with TCR-initiated activation. Cell imaging studies will decipher the membrane architecture of the CD4-CD8 T cell interaction platform and a whole genome siRNA screen will serve as an unbiased discovery tool to identify receptor-ligand pairs transmitting the negative signal.

Public Health Relevance

The autoimmune disease rheumatoid arthritis remains a major challenge as affected patients have a shorter life expectancy and have to take immune-suppressive drugs for decades. The immune system of RA patients lacks sufficient cells that hamper inflammation. The current project seeks to understand why such cells are not generated in RA patients, how such cells can inhibit joint inflammation and whether their mechanism-of-action can be exploited for novel therapeutic approaches.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56AI044142-13
Application #
8708382
Study Section
Special Emphasis Panel (ZRG1-IMM-N (02))
Program Officer
Peyman, John A
Project Start
1999-01-01
Project End
2014-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
13
Fiscal Year
2013
Total Cost
$369,035
Indirect Cost
$134,035
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Yanes, Rolando E; Gustafson, Claire E; Weyand, Cornelia M et al. (2017) Lymphocyte generation and population homeostasis throughout life. Semin Hematol 54:33-38
Shirai, Tsuyoshi; Nazarewicz, Rafal R; Wallis, Barbara B et al. (2016) The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. J Exp Med 213:337-54
Yang, Zhen; Shen, Yi; Oishi, Hisashi et al. (2016) Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis. Sci Transl Med 8:331ra38
Shirai, Tsuyoshi; Hilhorst, Marc; Harrison, David G et al. (2015) Macrophages in vascular inflammation--From atherosclerosis to vasculitis. Autoimmunity 48:139-51
Li, Guangjin; Ju, Jihang; Weyand, Cornelia M et al. (2015) Age-Associated Failure To Adjust Type I IFN Receptor Signaling Thresholds after T Cell Activation. J Immunol 195:865-74
Yang, Zhen; Matteson, Eric L; Goronzy, Jörg J et al. (2015) T-cell metabolism in autoimmune disease. Arthritis Res Ther 17:29
Whiting, Chan C; Siebert, Janet; Newman, Aaron M et al. (2015) Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging. PLoS One 10:e0133627
Weyand, Cornelia M; Yang, Zhen; Goronzy, Jörg J (2014) T-cell aging in rheumatoid arthritis. Curr Opin Rheumatol 26:93-100
Yang, Zhen; Goronzy, Jörg J; Weyand, Cornelia M (2014) The glycolytic enzyme PFKFB3/phosphofructokinase regulates autophagy. Autophagy 10:382-3
Jagger, Ann; Shimojima, Yasuhiro; Goronzy, Jorg J et al. (2014) Regulatory T cells and the immune aging process: a mini-review. Gerontology 60:130-7

Showing the most recent 10 out of 31 publications